Evidence map›Paper›PMID 30003887›Full record

ReviewJournal of molecular biology2018

Enabling Precision Medicine through Integrative Network Models.

Victoria Yao, Aaron K Wong, Olga G Troyanskaya

Abstract readReview
In one paragraph

Review in Journal of molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Network Interactions of Circulating FGF23, HRG-HMGB1, and Cardiac Disease in CKD.Journal of the American Society of Nephrology : JASN · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Precision medicine - networks to the rescue.Current opinion in biotechnology · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Victoria YaoDepartment of Computer Science, Princeton University, Princeton, NJ 08544, USA.
Aaron K WongCenter for Computational Biology, Flatiron Institute, Simons Foundation, New York, NY 10010, USA.
Olga G TroyanskayaDepartment of Computer Science, Princeton University, Princeton, NJ 08544, USA; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA; Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, NY 10010, USA. Electronic address: ogt@cs.princeton.edu.
Simons Foundation · USPrinceton University · US

Funding

Quantitavie and Computational Biology Graduate ProgramT32HG003284 · NHGRI · PRINCETON UNIVERSITY · PI Joshua Michael Akey, Stanislav Y. Shvartsman · 2004 to 2026
$9.9M
lntegration and Visualization of Diverse Biological DataR01GM071966 · NIGMS · PRINCETON UNIVERSITY · PI TROYANSKAYA, OLGA G · 2005 to 2022
$6.4M
NHGRI NIH HHS T32 HG003284NIGMS NIH HHS R01 GM071966
6 · The paper itself

Abstract

A key challenge in precision medicine lies in understanding molecular-level underpinnings of complex human disease. Biological networks in multicellular organisms can generate hypotheses about disease genes, pathways, and their behavior in disease-related tissues. Diverse functional genomic data, including expression, protein-protein interaction, and relevant sequence and literature information, can be utilized to build integrative networks that provide both genome-wide coverage as well as contextual specificity and accuracy. By carefully extracting the relevant signal in thousands of heterogeneous functional genomics experiments through integrative analysis, these networks model how genes work together in specific contexts to carry out cellular processes, thereby contributing to a molecular-level understanding of complex human disease and paving the way toward better therapy and drug treatment. Here, we discuss current methods to build context-specific integrative networks, focusing on tissue-specific networks. We highlight applications of these networks in predicting tissue-specific molecular response, identifying candidate disease genes, and increasing power by amplifying the disease signal in quantitative genetics data. Altogether, these exciting developments enable biomedical scientists to characterize disease from pathophysiology to cellular system and, finally, to specific gene alterations-making significant strides toward the goal of precision medicine.

Indexed as

Disease SusceptibilityModels, BiologicalNeural Networks, ComputerPrecision MedicineAnimalsGenetic Predisposition to DiseaseHumansSpecies Specificityintegrative networksquantitative genetics datatissue specificity

Identifiers

PMID30003887
PMCPMC13037550
OpenAlexW2823486014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.